کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
9002283 | 1118581 | 2005 | 8 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Inhibitory effects on human eosinophil chemotaxis in vitro by BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
SGC3-isobutyl-l-methyl-xanthineS-nitroso-N-acetylpenicillaminecAMP levelsBAY 41-2272SIN-1YC-1ODQfMLPcyclic adenosine-3′,5′-monophosphatePDEIBMXcGMP3-morpholinosydnonimine - 3-مورفولینویدونیمینیمcAMP - cAMPMTT - MTTEosinophil - ائوزینوفیلMinimum Essential Medium Eagle - حداقل عقاب متوسط ضروریCytotoxicity - سمیت سلولیSoluble guanylate cyclase - سیکلاس گوانیلات حل کنندهSNAP - ضربه محکم و ناگهانیFormyl-methionyl-leucyl-phenylalanine - فرمول متیونیل-لوسیل-فنیل آلانینPhosphodiesterase - فسفو دی استرازMEM - مامانsodium nitroprusside - نیتروپروساید سدیمNitric oxide - نیتریک اکسیدSNP - چندریختی تک-نوکلئوتیدChemotaxis - کموتاکسیcyclic guanosine-3′,5′-monophosphate - گنوزین سیکل 3 '، 5'-مونوفسفره
موضوعات مرتبط
علوم پزشکی و سلامت
داروسازی، سم شناسی و علوم دارویی
داروشناسی
پیش نمایش صفحه اول مقاله

چکیده انگلیسی
This study was designed to investigate the effects of the 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-pyrimidin-4-ylamine (BAY 41-2272) on formyl-methionyl-leucyl-phenylalanine (fMLP; 10â7 M)-induced human eosinophil chemotaxis, cyclic guanosine-3â²,5â²-monophosphate (cGMP) and cyclic adenosine-3â²,5â²-monophosphate (cAMP) levels. Human eosinophils were pretreated or not with 3-isobutyl-l-methyl-xanthine (IBMX; 500 μM), and then exposed to BAY 41-2272 (0.1-10.0 μM) for either short (10 min) or prolonged (90 min) time periods. Exposition of eosinophils with BAY 41-2272 for either 10 min or 90 min markedly inhibited the eosinophil chemotaxis, independently of IBMX pretreatment. Inhibition of fMLP-induced eosinophil chemotaxis by BAY 41-2272 (in absence of prior treatment with IBMX) was about of the same irrespective if cells were exposed for 10 min or 90 min with this compound. In IBMX-pretreated eosinophils, the inhibition of fMLP-induced chemotaxis by BAY 41-2272 in the 10-min exposure protocols was even higher in comparison with the 90-min protocols. Incubation of IBMX-treated eosinophils for 90 min with BAY 41-2272 resulted in 2.0-2.5 times higher levels of cGMP and cAMP compared with the 10-min protocols. The BAY 41-2272-induced cGMP increases were abolished by pre-incubation of eosinophils with the soluble guanylate cyclase inhibitor 1H-[1,2,4]-oxidiazolo[4,3-a] quinoxalin-1-one (ODQ). No eosinophil toxicity was observed in any experimental condition, according to 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide (MTT) assay. Our findings show that inhibitory effects of fMLP-induced human eosinophil chemotaxis by BAY 41-2272 at short-term or prolonged exposition time are accompanied by significant elevations of cGMP and cAMP, but we could not detect a clear correlation between chemotaxis inhibition and elevation of cyclic nucleotide levels.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Biochemical Pharmacology - Volume 69, Issue 6, 15 March 2005, Pages 875-882
Journal: Biochemical Pharmacology - Volume 69, Issue 6, 15 March 2005, Pages 875-882
نویسندگان
Sara M. Thomazzi, Juliana Moreira, Gilberto De Nucci, Edson Antunes,